Aurinia Pharmaceuticals Inc. (AUPH) Operating margin 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) operating margin by fiscal year — reported operating income divided by reported revenue.
37.1%FY2025 · since FY2018: -11930.9% → 37.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 37.1% | +39.1 pp |
| FY2024 | -2.0% | +50.2 pp |
| FY2023 | -52.2% | +30.9 pp |
| FY2022 | -83.2% | +313.1 pp |
| FY2021 | -396.3% | -188.2 pp |
| FY2020 | -208.1% | +28390.3 pp |
| FY2019 | -28598.4% | -16667.5 pp |
| FY2018 | -11930.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Net marginAUPH Gross profitAUPH Gross marginAUPH Operating incomeAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →